PharmaCyte Biotech Inc (PMCB): http://www.xconomy.com/san-francisco/201...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	56
Posts	1134
Boards Moderated	1
Alias Born	01/13/2017

Triple9

Re: SirCharChar post# 75139

Friday, 09/15/2017 9:23:49 AM

Friday, September 15, 2017 9:23:49 AM

http://www.xconomy.com/san-francisco/2017/05/30/protagonist-janssen-ink-development-deal-for-crohns-disease-drug/#

This stock went from $8.22 to $11.82 when news broke of its partnership. Currently trading at $15.36

http://ir.tesarobio.com/releasedetail.cfm?releaseid=963728

This stock went from $41.44 to $46.30 when news broke of its partnership. Currently trading at $115.24.

Apples and Oranges in a big sense however. These companies already had funding from IPOs when Janssen partnered with them. Clearly having a powerhouse like J&J behind you is huge and bodes very well for the company. But what we have at PMCB is night and day.

I'd say without a strong lawyer like KW at the helm PMCB would get the short end of any deal with a partner. So count your blessings for KW and for our new law firm Pepper Hamilton.

Know What You Own. My posts should not be construed as investment advice.